Skip to main content
CivicGate

HR 6400
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Rx ACCESS Act

To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes.

Introduced Dec 3, 2025

Latest action (Dec 3, 2025) Referred to the House Committee on Armed Services.

Summary

This bill would improve medication access and fairness under the TRICARE pharmacy benefits program for military personnel and families. Beginning October 1, 2026, beneficiaries would be able to choose to receive non-generic prescription maintenance medications through any available pharmacy option. The bill establishes minimum reimbursement standards for pharmacies, requiring payment based on the actual cost of acquiring medications plus a professional dispensing fee, and prohibits contractors from imposing additional fees on pharmacies. The bill requires the Comptroller General to conduct annual audits to review reimbursement rates, price concessions, and whether the pharmacy network provides adequate access, especially in rural areas. The Secretary of Defense must submit an implementation plan to Congress within 90 days of the law's enactment.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Actions (2)

  1. Dec 3, 2025 Referred to the House Committee on Armed Services. · house
  2. Dec 3, 2025 Introduced in House

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Text versions (1)

  • Introduced in House · Dec 3, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

December 3, 2025

Mrs. Kiggans of Virginia (for herself, Ms. Goodlander, Mr. Luttrell, and Ms. Houlahan) introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Rx Access, Choice, Cost Equity, and Supply Stability Act” or the “Rx ACCESS Act”.

SEC. 2. IMPROVEMENTS RELATING TO ACCESS, FAIRNESS, AND TRANSPARENCY UNDER TRICARE PHARMACY BENEFITS PROGRAM.

(a) Beneficiary Election of Prescription Refill Means.—Section 1074g(a)(9) of title 10, United States Code, is amended—

(1) in subparagraph (A), by inserting “, and ending on October 1, 2026” after “Beginning on October 1, 2015”; and

(2) by adding at the end the following new subparagraph:

“(D) Beginning on October 1, 2026, an eligible covered beneficiary may elect to receive non-generic prescription maintenance medications through any means described in paragraph (2)(E).”.

(b) Pharmacy Benefit Manager Reimbursement Standards; Independent Audits.—Section 1074g of title 10, United States Code, as amended by subsection (a), is further amended—

(1) by redesignating subsections (i) and (j) as subsections

(j) and (k), respectively; and

(2) by inserting after subsection (h) the following new subsection:

“(i) Pharmacy Benefit Manager Reimbursement Standards.—(1) The Secretary of Defense shall ensure that, as a condition of any contract entered into for the administration of the TRICARE pharmacy benefits program, reimbursement to a TRICARE retail pharmacy described in subsection (a)(2)(E)(ii) for a pharmaceutical agent provided under such program shall be an amount that is at least equal to the sum of—

“(A) either—

“(i) the actual cost to the pharmacy of acquiring such pharmaceutical agent from a wholesaler, or

“(ii) in the case of a pharmaceutical agent included on the national average drug acquisition cost index published by the Administrator for the Centers for Medicare and Medicaid Services, a proxy amount calculated at a rate that is not lower than the national average acquisition cost for such pharmaceutical agent, as identified on such cost index as of the date of the adjudication of the claim for such reimbursement, and

“(B) a professional dispensing fee that is equal to the professional dispensing fee paid by the State in which the pharmacy is located under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) for dispensing a prescription drug.

“(2) The contractor administering the TRICARE pharmacy benefits program may not impose any fees on a TRICARE retail pharmacy, including point-of-sale fees, retroactive fees, or other indirect or hidden fees.

“(3)(A) Not less frequently than annually, the Comptroller General of the United States—

“(i) shall conduct an audit of—

“(I) data reported by the contractor responsible for the administration of the TRICARE pharmacy benefits program relating to the rates of reimbursement under paragraph (1) and any price concessions; and

“(II) the adequacy of the TRICARE retail pharmacy network and access by eligible covered beneficiaries to such network, including with respect to continuity of care, geographic accessibility (taking into account factors in addition to travel time to and from a pharmacy, with special consideration for rural and underserved areas), and the extent to which elections by such beneficiaries under subsection (a)(9) reflect personal preference; and

“(ii) submit the results of such audit to the Committees on Armed Services of the House of Representatives and the Senate.

“(B) The Secretary shall ensure that, as a condition of any contract entered into for the administration of the TRICARE pharmacy benefits program, the contractor provides the Comptroller General information required to conduct the audit under subparagraph (A).”.

(c) Report.—Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees (as defined in section 101(a)(16) of title 10, United States Code) a plan for the implementation of this section. <all>

Comments

Comments

Loading comments…